Preclinical and early clinical study of forodesine hydrochloride (FH) in chronic lymphocytic leukemia (CLL).

被引：0
|
作者：
Balakrishnan, Kumudha [1 ]
Nimmanapalli, Ramadevi [1 ]
Keating, Michael J. [1 ]
Ravandi, Farhad [1 ]
Gandhi, Varsha [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5657
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Development of forodesine hydrochloride (FH), an inhibitor of purine nucleoside phosphorylase, for patients with chronic lymphocytic leukemia (CLL).
    Balakrishnan, K
    Ravandi, F
    Keating, MJ
    Gandhi, V
    BLOOD, 2005, 106 (11) : 599A - 599A
  • [2] Clinical Significance of Apoptosis in Chronic Lymphocytic Leukemia (CLL)
    Del Poeta, Giovanni
    Del Principe, Maria Ilaria
    Dal Bo, Michele
    Buccisano, Francesco
    Ragusa, Dario
    Pozzo, Federico
    Bulian, Pietro
    Maurillo, Luca
    Rossi, Davide
    Venditti, Adriano
    de Fabritiis, Paolo
    Gaidano, Gianluca
    Amadori, Sergio
    Gattei, Valter
    BLOOD, 2014, 124 (21)
  • [3] Phase II, Single Center Study of Oral Forodesine in Patients with Advanced, Fludarabine-Treated Chronic Lymphocytic Leukemia (CLL)
    Verma, Dushyant
    Balakrishnan, Kumudha
    O'Brien, Susan
    Thomas, Deborah A.
    Ferrajoli, Alessandra
    Wierda, William G.
    Verma, Amit
    Faderl, Stefan
    Bickel, Susan M.
    Bantia, Shanta
    Kantarjian, Hagop M.
    Keating, Michael J.
    Gandhi, Varsha
    Ravandi, Farhad
    BLOOD, 2009, 114 (22) : 935 - 936
  • [4] Limited clinical significance of cytogenetics in chronic lymphocytic leukemia (CLL).
    Keating, MJ
    Garson, OM
    Lerner, S
    OBrien, S
    Hayes, K
    Kantarjian, H
    BLOOD, 1996, 88 (10) : 3610 - 3610
  • [5] Sequential treatment of chronic lymphocytic leukemia (CLL) with Bryostatin I and 2-chlorodeoxyadenosine: A preclinical study
    Katato, K
    Mohammad, RM
    Dugan, MC
    Saleh, M
    Ahmad, I
    Almatchy, VP
    Varterasian, ML
    AlKatib, A
    BLOOD, 1996, 88 (10) : 2349 - 2349
  • [6] MORE ON EARLY CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) - CLINICAL STAGING SYSTEMS AND INDICATIONS FOR TREATMENT
    JAKSIC, B
    KUSEC, R
    HEMATOLOGIC PATHOLOGY, 1992, 6 (04) : 219 - 221
  • [7] PSEUDOHYPERKALEMIA IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    Abdulrahman, Rula
    Saxena, Ramesh
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 73 (05) : 643 - 643
  • [8] Chronic lymphocytic leukemia (CLL)Then and now
    Rai, Kanti R.
    Jain, Preetesh
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (03) : 330 - 341
  • [9] PROGNOSIS FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    PHILLIPS, E
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 274 - 274
  • [10] CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) FOLLOWED BY AN ACUTE MONOCYTIC LEUKEMIA (AML) (CLINICAL AND CYTOLOGICAL STUDY)
    LEJEUNE, F
    KRITVITZKY, A
    AUDROUIN, C
    CASASSUS, P
    BRIERE, J
    LORTHOLARY, P
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1983, 25 (04): : 245 - 251
12345